Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2844 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Novartis terminates development of Aurograb

According to the company, an intangible asset impairment charge of approximately $235 million, which reflects the full amount allocated to this project, will be taken in the third

All-Med Services of Florida names new CEO

In this role, Mr King-Shaw will be responsible for leading the companies’s strategic growth while addressing changing market conditions and patient demand. Raul Rodriguez, who founded both companies,

Cutera introduces new Pearl Fractional device

The company said that it will begin sales and marketing activities in the US, Europe and Australia. Pearl Fractional, with its proprietary 2,790nm wavelength, is the company’s solution